Cargando…

Impact of the COVID-19 pandemic on the conduct of clinical trials: a quantitative analysis

BACKGROUND: Globally, healthcare has shouldered much of the socioeconomic brunt of the COVID-19 pandemic leading to numerous clinical trials suspended or discontinued. OBJECTIVE: To estimate the COVID-19 impact on the number of clinical trials worldwide. METHODS: Data deposited by 219 countries in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Margas, Wojciech, Wojciechowski, Piotr, Toumi, Mondher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Routledge 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367669/ https://www.ncbi.nlm.nih.gov/pubmed/35968522 http://dx.doi.org/10.1080/20016689.2022.2106627

Ejemplares similares

The real-life impact of vaccination on COVID-19 mortality in Europe and Israel
por: Jabłońska, Katarzyna, et al.
Publicado: (2021)

Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al
por: Toumi, Mondher, et al.
Publicado: (2020)

On the association between SARS-COV-2 variants and COVID-19 mortality during the second wave of the pandemic in Europe
por: Jabłońska, Katarzyna, et al.
Publicado: (2021)

Risk of discontinuation of Advanced Therapy Medicinal Products clinical trials
por: Hanna, Eve, et al.
Publicado: (2016)

Factors influencing the COVID-19 daily deaths' peak across European countries
por: Jabłońska, Katarzyna, et al.
Publicado: (2021)

Mapping the EORTC QLQ-C30 onto the EQ-5D-5L index for patients with paroxysmal nocturnal hemoglobinuria in France
por: Wojciechowski, Piotr, et al.
Publicado: (2023)

Gene therapy randomised clinical trials in Europe – a review paper of methodology and design
por: Ilieva, Krassimira, et al.
Publicado: (2020)

The impact of COVID-19 on the cell and gene therapies industry: Disruptions, opportunities, and future prospects
por: Qiu, Tingting, et al.
Publicado: (2021)

Drug repurposing in pharmaceutical industry and its impact on market access: market access implications
por: Murteira, Susana, et al.
Publicado: (2014)

Benefits of probabilistic sensitivity analysis – a review of NICE decisions
por: Adalsteinsson, Erpur, et al.
Publicado: (2013)

Conducting dermatology clinical trials during the COVID-19 pandemic
por: Sheriff, Tabrez, et al.
Publicado: (2021)

The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea
por: Jeon, JuYeun, et al.
Publicado: (2020)

New drug regulations in France: what are the impacts on market access? Part 1 – Overview of new drug regulations in France
por: Rémuzat, Cécile, et al.
Publicado: (2013)

Impact of the COVID-19 pandemic on the conduct of non-COVID-19 clinical trials: protocol for a scoping review
por: Shang, Wenru, et al.
Publicado: (2023)

Effectiveness and Safety of Nonvitamin K Oral Anticoagulants Rivaroxaban and Apixaban in Patients with Venous Thromboembolism: A Meta-Analysis of Real-World Studies
por: Wu, Olivia, et al.
Publicado: (2022)

New drug regulations in France: what are the impacts on market access? Part 2 – impacts on market access and impacts for the pharmaceutical industry
por: Rémuzat, Cécile, et al.
Publicado: (2013)

“Direct and indirect impacts of the COVID-19 pandemic on operational conduct of pediatric vaccine clinical trials”
por: McArthur, Monica Anne, et al.
Publicado: (2023)

Economic impact of new active substance status on EU payers’ budgets: example of dimethyl fumarate (Tecfidera(®)) for multiple sclerosis
por: Toumi, Mondher, et al.
Publicado: (2014)

A critical analysis and review of Lancet COVID-19 hydroxychloroquine study
por: Toumi, Mondher, et al.
Publicado: (2020)

Effectively Conducting Oncology Clinical Trials During the COVID-19 Pandemic
por: Yeboa, Debra Nana, et al.
Publicado: (2021)

The impact of COVID-19 pandemic on conducting emergency medicine clinical research
por: Ehrlich, Haley, et al.
Publicado: (2021)

Economic Impact of a triptan Rx-To-OTC Switch in Six EU Countries
por: Millier, Aurelie, et al.
Publicado: (2013)

Economic and health implications from earlier detection of HIV infection in the United Kingdom
por: Zah, Vladimir, et al.
Publicado: (2016)

The COVID-19 pandemic and a reflection on the conduct of clinical trials in times of war
por: Pacheco, Rafael Leite, et al.
Publicado: (2021)

Value added medicines: what value repurposed medicines might bring to society?
por: Toumi, Mondher, et al.
Publicado: (2016)

The Market Access Society launches a new journal
por: Toumi, Mondher
Publicado: (2013)

From investigational product to active reference: evolution of oral sumatriptan efficacy versus placebo for the treatment of acute migraine episodes and potential impact in comparative analyses
por: Thokagevistk, Katia, et al.
Publicado: (2019)

Letter to the Editor: “The impact of COVID-19 pandemic on the initiation of interventional clinical trials conducted in intensive care units”
por: Huang, Chanyan, et al.
Publicado: (2022)

Conducting clinical trials during the COVID-19 pandemic—a collaborative trial network response
por: Robison, Laura, et al.
Publicado: (2021)

On the Methodological Aspects of the Clinical Trials for COVID-19 Conducted in the First Year of the Pandemic: A Descriptive Analysis
por: Georgiadi, Eleni, et al.
Publicado: (2023)

The Impact of the COVID-19 Pandemic on Children’s Conduct Problems and Callous-Unemotional Traits
por: Waller, Rebecca, et al.
Publicado: (2021)

How the COVID-19 pandemic is changing clinical trial conduct and driving innovation in bioanalysis
por: Anderson, Melanie
Publicado: (2021)

Drug pricing reform in China: analysis of piloted approaches and potential impact of the reform
por: Chen, Yixi, et al.
Publicado: (2016)

Conflict of interest in Health Technology Assessment decisions: case law in France and impact on reimbursement decisions
por: Frybourg, Sandrine, et al.
Publicado: (2015)

The impact of amortization of gene therapies funding on the results and conclusions of CEMs and BIMs
por: Polek, Hubert, et al.
Publicado: (2023)

Characteristics of doctor-shoppers: a systematic literature review
por: Biernikiewicz, Małgorzata, et al.
Publicado: (2019)

Market access agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts
por: Jarosławski, Szymon, et al.
Publicado: (2011)

National Immunization Therapeutic Advisory Group: it is time for experience sharing and best practice learning
por: Ricciardi, Walter, et al.
Publicado: (2015)

Introduction
por: Toumi, Mondher, et al.
Publicado: (2015)

Non-profit drug research and development: the case study of Genethon
por: Jarosławski, Szymon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8cqj5gebbq2f8ohjjogv1gbhrc